Updates in NHL Management vs VizaView Utilisation & Stats
In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have been developed. These therapies include anti-CD20 antibodies and chimeric antigen receptor T-cell (CAR-T) therapies. With continued developments in NHL management, bispecific antibodies are a promising strategy for use in the relapsed/refractory setting with promising data showing potential for improving outcomes in patient care.
- Apple App Store
- Gratuit
- Médical
Classement dans le store
- -
VizaView is a Vizamyl™ case-based review application designed to enhance the case reading ability of trained imagers. This tool is intended for informational purposes only and is not a replacement or substitute for the required Vizamyl™ Reader Training Program. If you have clinical or scientific questions regarding the content of this app, please contact GE Medical Affairs 800 654 0118 (option 2, then option 3) or medical.affairs@ge.com.
- Apple App Store
- Gratuit
- Médical
Classement dans le store
- -
Updates in NHL Management VS. 
VizaView17écembre d, 2024